ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,287.60
      0.00%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      80.465
      -0.19%
      Bitcoin
      93,291.35
      -1.27%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Theracryf Plc (TCF) Quote

      Theracryf Plc

      Theracryf Plc (TCF)

      360 Capital Mortgage REIT
      Trillion Energy International Inc
      0.75
      0.00
      ( 0.00% )
      Updated: 03:00:00
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.75
      Bid
      0.70
      Ask
      0.80
      Volume
      0.00
      0.75 Day's Range 0.75
      0.525 52 Week Range 35.00
      Market Cap
      3.222M
      Previous Close
      0.75
      Open
      0.75
      Last Trade
      (O)
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      578,585
      Shares Outstanding
      429,622,422
      Dividend Yield
      -
      PE Ratio
      -1.03
      Earnings Per Share (EPS)
      -0.01
      Revenue
      396k
      Net Profit
      -3.14M

      About Theracryf Plc

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.theracryf.com
      Headquarters
      Cheshire, Gbr
      Founded
      -
      Theracryf Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TCF. The last closing price for Theracryf was 0.75p. Over the last year, Theracryf shares have traded in a share price range of 0.525p to 35.00p.

      Theracryf currently has 429,622,422 shares outstanding. The market capitalization of Theracryf is £3.22 million. Theracryf has a price to earnings ratio (PE ratio) of -1.03.

      Ask ADVFN Intelligence (AI)

      TCF Latest News

      More News

      TheraCryf narrows loss, advances drug programmes after acquisition

      TheraCryf PLC said on Thusday its half-year pretax loss narrowed as it advanced drug development programmes in oncolo ...

      November 28 2024
      Alliance News

      Theracryf PLC Half-year Report

      Theracryf PLC 28 November 2024   TheraCryf plc   ("TheraCryf" or "the Company" or "the Group")   Half Year Report to 30 September 2024      Alderley Park, UK 28 November 2024. TheraCryf plc...

      November 28 2024
      RNS Regulatory News

      TheraCryf gets European patent for drug acquired from new subsidiary

      TheraCryf PLC on Wednesday confirmed it had been awarded a Composition of Matter patent in Europe for a new drug trea ...

      November 27 2024
      Alliance News

      Theracryf PLC European Patent Office award decision

      Theracryf PLC 27 November 2024   RNS REACH TheraCryf plc ("TheraCryf", the "Company" or the "Group") European Patent Office decision to award patent for Ox-1 antagonist   Alderley Park, UK...

      November 27 2024
      RNS Non-Regulatory

      Theracryf PLC Holding(s) in Company

      Theracryf PLC 15 November 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BSVYN304 Issuer Name THERACRYF PLC UK or Non-UK Issuer UK 2. Reason for...

      November 15 2024
      RNS Regulatory News

      Theracryf PLC Issue of Equity and Total Voting Rights

      Theracryf PLC 14 November 2024     TheraCryf plc ("TheraCryf", the "Company" or the "Group") Issue of Equity and Total Voting Rights Alderley Park, UK - 14 Nov 2024: TheraCryf plc (AIM:...

      November 14 2024
      RNS Regulatory News

      Theracryf PLC Notice of Results

      Theracryf PLC 14 November 2024   TheraCryf plc ("TheraCryf", the "Company" or the "Group")   Notice of Interim results and Presentation via Investor Meet Company   Alderley Park, 14 November...

      November 14 2024
      RNS Regulatory News

      Theracryf PLC Publication of peer reviewed data

      Theracryf PLC 11 November 2024   RNS REACH TheraCryf plc ("TheraCryf", the "Company" or the "Group") Publication of peer reviewed data on healthy volunteer pharmacokinetic study of SFX-01...

      November 11 2024
      RNS Non-Regulatory

      EXECUTIVE CHANGES: Sanderson hires in UK and US; Oberon gets Penny

      The following is a round-up of London-listed company director and manager changes announced on Friday and Monday and ...

      November 04 2024
      Alliance News

      Theracryf PLC Passing of Dr Sue Foden, Chair

      Theracryf PLC 04 November 2024     TheraCryf plc ("TheraCryf", the "Company" or the "Group") Passing of  Dr Sue Foden, Chair Alderley Park, UK - 4 November 2024: TheraCryf plc (AIM: TCF), the...

      November 04 2024
      RNS Regulatory News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1000.750.750.7510000410.75DE
      40.22542.85714285710.5250.750.52510236270.68736954DE
      120.125200.6250.750.5255785850.62228887DE
      26-0.05-6.250.80.90.5256032470.68926141DE
      52-34.25-97.857142857135350.5255598940.77320052DE
      156-34.25-97.857142857135350.5251881070.77320052DE
      260-34.25-97.857142857135350.5251124200.77320052DE

      TCF - Frequently Asked Questions (FAQ)

      What is the current Theracryf share price?
      The current share price of Theracryf is 0.75p
      How many Theracryf shares are in issue?
      Theracryf has 429,622,422 shares in issue
      What is the market cap of Theracryf?
      The market capitalisation of Theracryf is GBP 3.22M
      What is the 1 year trading range for Theracryf share price?
      Theracryf has traded in the range of 0.525p to 35.00p during the past year
      What is the PE ratio of Theracryf?
      The price to earnings ratio of Theracryf is -1.03
      What is the cash to sales ratio of Theracryf?
      The cash to sales ratio of Theracryf is 8.33
      What is the reporting currency for Theracryf?
      Theracryf reports financial results in GBP
      What is the latest annual turnover for Theracryf?
      The latest annual turnover of Theracryf is GBP 396k
      What is the latest annual profit for Theracryf?
      The latest annual profit of Theracryf is GBP -3.14M
      What is the registered address of Theracryf?
      The registered address for Theracryf is ALDERLEY PARK, CONGLETON ROAD, NETHER ALDERLEY, CHESHIRE, SK10 4TG
      What is the Theracryf website address?
      The website address for Theracryf is www.theracryf.com
      Which industry sector does Theracryf operate in?
      Theracryf operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 66.00
      (0.00%)
      		1.65k
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 66.00
      (0.00%)
      		1.65k
      0R0XTesla Inc
      $ 388.20
      (0.00%)
      		4.74k
      0JOQJd.com Inc
      $ 72.00
      (0.00%)
      		3.03k
      0HCIAlibaba Group Holding Ltd
      $ 81.10
      (0.00%)
      		2.3k
      0R1OAmazon.com Inc
      $ 217.50
      (0.00%)
      		1.67k
      0P4FFord Motor Co
      $ 9.665
      (0.00%)
      		1.67k

      Discussion

      View Full Feed
      DiamondHealer95 DiamondHealer95 2 minutes ago
      I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years 🤪
      KBLB
      DiamondHealer95 DiamondHealer95 6 minutes ago
      We've invested similarly
      KBLB
      sunspotter sunspotter 17 minutes ago
      Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
      VPLM
      Flobewan Flobewan 28 minutes ago
      Marc loved your ides
      tinojax tinojax 29 minutes ago
      I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
      PLUG
      mrfence mrfence 31 minutes ago
      Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
      [yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
      FMCC FNMA
      IVRT IVRT 47 minutes ago
      In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
      BMXI
      DewDiligence DewDiligence 47 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      ENTA
      DewDiligence DewDiligence 48 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      Guido2 Guido2 49 minutes ago
      This is DUE DILIGENCE! Thank you Free Fannie.

      https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
      FNMA
      StockItOut StockItOut 56 minutes ago
      That Xeriant PR excellently written with bullshit:

      ""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

      "the Company used the data to make several key
      XERI
      gitreal gitreal 59 minutes ago
      You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
      BMXI
      RichieBoy RichieBoy 1 hour ago
      Jim wrote a blurb about seeking more US business.

      Help you out any? 🤨
      AFFU
      DesktopDR DesktopDR 1 hour ago
      Any news or updates?
      VPLM
      Tahoe2468 Tahoe2468 1 hour ago
      .0915 by Thursday....... 
      KRTL
      skitahoe skitahoe 1 hour ago
      Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

      According to Google, GBM ha
      NWBO
      fuagf fuagf 1 hour ago
      You are right about the crafty, evil, smart. Authoritarian methods have been in full view
      in capturing America. While we work to do the right things they plot to capture the lot.
      facts_matter14 facts_matter14 1 hour ago
      If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






      .
      SRMX
      StockItOut StockItOut 1 hour ago
      Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
      XERI
      fuagf fuagf 1 hour ago
      He would smother any question with words.
      Shawonsarker84 Shawonsarker84 1 hour ago
      $HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



      https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
      HMBL XTIA
      chen1992 chen1992 1 hour ago
      https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

      https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
      TGLO
      FNM500K FNM500K 1 hour ago
      Oh noooooo.....
      FNMA
      StockItOut StockItOut 1 hour ago
      OTC filings and attorney statements. my error.

      Point that it is on you to prove your claim, that:
      "There's no contract employees. There's no production shafts."

      Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

      I
      BMXI

      Your Recent History

      LSE
      TCF
      Theracryf
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads